This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Granér, M. Articles by Taskinen, M.-R. Search for Related Content PubMed PubMed Citation Articles by Granér, M. Articles by Taskinen, M.-R.

Association of Paraoxonase-1 Activity and Concentration With Angiographic Severity and Extent of Coronary Artery Disease

Marit Granér, MD^_*,_*, Richard W. James, MD, PhD, Juhani Kahri, MD, PhD,^_*, Markku S. Nieminen, MD, PhD^_*, Mikko Syvänne, MD, PhD^_* and Marja-Riitta Taskinen, MD, PhD^_*

^_* Department of Internal Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Clinical Diabetes Unit, Division of Endocrinology and Diabetology, University Hospital, Geneva, Switzerland

View larger version (18K): [in a new window]   Figure 1 Box plot shows median (horizontal lines), 25th to 75th percentiles (boxes), and 95th percentiles (whiskers) of paraoxonase-1 (PON1) activity (A) and PON1 concentration (B) by visual angiographic coronary artery disease (CAD) status.

View larger version (15K): [in a new window]   Figure 2 Relationship between paraoxonase-1 (PON1) activity tertile by global percent diameter stenosis (PDS) index (A), global extent index (B), and global atheroma burden index (C), respectively. For definition of the indexes, see the Methods section.